Evidence map›Paper›PMID 35867735›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

ATG7 is a haploinsufficient repressor of tumor progression and promoter of metastasis.

Jaclyn S Long, Elżbieta Kania, David G McEwan, Valentin J A Barthet, Martina Brucoli, Marcus J G W Ladds, Christoph Nössing, Kevin M Ryan

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Atg7 in CD4Clinical and translational medicine · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Lower Serum ATG7 Levels Linked to Insulin Resistance in Women with Polycystic Ovary Syndrome.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Autophagy and autophagy-related pathways in cancer.Nature reviews. Molecular cell biology · 2023
    Review
  13. Review
  14. Article
  15. ATG7 is a haploinsufficient repressor of tumor progression and promoter of metastasis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jaclyn S LongTumour Cell Death and Autophagy Laboratory, Cancer Research UK Beatson Institute, Glasgow, G61 1BD, United Kingdom.ORCID 0000-0002-6644-542X
Elżbieta KaniaTumour Cell Death and Autophagy Laboratory, Cancer Research UK Beatson Institute, Glasgow, G61 1BD, United Kingdom.ORCID 0000-0002-6530-9549
David G McEwanTumour Cell Death and Autophagy Laboratory, Cancer Research UK Beatson Institute, Glasgow, G61 1BD, United Kingdom.
Valentin J A BarthetTumour Cell Death and Autophagy Laboratory, Cancer Research UK Beatson Institute, Glasgow, G61 1BD, United Kingdom.ORCID 0000-0002-5396-3594
Martina BrucoliTumour Cell Death and Autophagy Laboratory, Cancer Research UK Beatson Institute, Glasgow, G61 1BD, United Kingdom.ORCID 0000-0001-5973-9924
Marcus J G W LaddsTumour Cell Death and Autophagy Laboratory, Cancer Research UK Beatson Institute, Glasgow, G61 1BD, United Kingdom.
Christoph NössingTumour Cell Death and Autophagy Laboratory, Cancer Research UK Beatson Institute, Glasgow, G61 1BD, United Kingdom.ORCID 0000-0003-0599-8458
Kevin M RyanTumour Cell Death and Autophagy Laboratory, Cancer Research UK Beatson Institute, Glasgow, G61 1BD, United Kingdom.ORCID 0000-0002-1059-9681
Cancer Research UK Scotland Institute · GB

Funding

Cancer Research UK 15816Cancer Research UK C596
6 · The paper itself

Abstract

The role of autophagy in cancer is complex. Both tumor-promoting and tumor-suppressive effects are reported, with tumor type, stage and specific genetic lesions dictating the role. This calls for analysis in models that best recapitulate each tumor type, from initiation to metastatic disease, to specifically understand the contribution of autophagy in each context. Here, we report the effects of deleting the essential autophagy gene

Indexed as

Autophagy-Related Protein 7Carcinoma, Pancreatic DuctalPancreatic NeoplasmsAnimalsCell Line, TumorMiceMutationNeoplasm InvasivenessProto-Oncogene Proteins p21(ras)SuccinatesAtg7 protein, mouseAutophagy-Related Protein 7Proto-Oncogene Proteins p21(ras)SuccinatesATG7autophagymetastasispancreatic cancer

Identifiers

PMID35867735
PMCPMC9282388
OpenAlexW4286630858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.